Nuveen
PRNB

Nuveen’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Nuveen’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-211,515
Closed -$12.6M – 3358
2020
Q2 		$12.6M Buy
211,515
+62,935
+42% +$3.89M 0.01% 1326
2020
Q1 		$8.82M Sell
148,580
-173,510
-54% -$10.1M ﹤0.01% 1370
2019
Q4 		$17.6M Buy
322,090
+163,508
+103% +$6.11M 0.01% 1246
2019
Q3 		$4.48M Buy
158,582
+101,776
+179% +$3.73M ﹤0.01% 2020
2019
Q2 		$1.89M Buy
+56,806
New +$1.77M ﹤0.01% 2468

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Nuveen's PRNB Position: Q3 2020 in Review

Nuveen sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 211,515 shares — an estimated $12.6M sold.

Nuveen first reported a position in PRNB in Q2 2019 and held it in 5 quarters. The position peaked at $17.6M in Q4 2019. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Nuveen reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Nuveen sold 211,515 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $12.6M.
  • Nuveen first reported a position in Principia Biopharma Inc. Common Stock in Q2 2019 and held it in 5 quarters.
  • Nuveen's Principia Biopharma Inc. Common Stock position peaked at $17.6M in Q4 2019.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Nuveen's 13F filing for Q3 2020, filed 16 Nov 2020.